INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Total Expenditure History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹85 Cr | ₹62 Cr | ₹52 Cr | ₹43 Cr | ₹35 Cr |
What is the latest Total Expenditure of INDO US BIOTECH ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹35 Cr |
How is Total Expenditure of INDO US BIOTECH Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹85 Cr | 36.87 | |
| Mar2024 | ₹62 Cr | 18.49 | |
| Mar2023 | ₹52 Cr | 21.40 | |
| Mar2022 | ₹43 Cr | 24.73 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Expenditure of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹253.1 Cr | 0.7% | 4.9% | -42.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,397.8 Cr | 3.5% | -6.6% | -17.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,581.4 Cr | -1.5% | -5.3% | -7.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,255.7 Cr | 5.7% | 2.2% | -12.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹962.3 Cr | 3.9% | -12.4% | -44.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹406.0 Cr | 5.7% | -11.2% | -6.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 0.7% |
4.9% |
-42.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses